Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Persistent cannabis users show neuropsychological decline from childhood to midlife.

Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RS, McDonald K, Ward A, Poulton R, Moffitt TE.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64. doi: 10.1073/pnas.1206820109. Epub 2012 Aug 27.

PMID:
22927402
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia.

Volk DW, Lewis DA.

Curr Neuropharmacol. 2005 Jan;3(1):45-62.

PMID:
22545031
[PubMed]
Free PMC Article
3.

Cannabis use and cognitive dysfunction.

Shrivastava A, Johnston M, Tsuang M.

Indian J Psychiatry. 2011 Jul;53(3):187-91. doi: 10.4103/0019-5545.86796. No abstract available.

PMID:
22135433
[PubMed]
Free PMC Article
4.

Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans.

Steinmetz AB, Edwards CR, Vollmer JM, Erickson MA, O'Donnell BF, Hetrick WP, Skosnik PD.

Psychopharmacology (Berl). 2012 May;221(1):133-41. doi: 10.1007/s00213-011-2556-1. Epub 2011 Dec 2.

PMID:
22134474
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Age of onset of marijuana use and executive function.

Gruber SA, Sagar KA, Dahlgren MK, Racine M, Lukas SE.

Psychol Addict Behav. 2012 Sep;26(3):496-506. doi: 10.1037/a0026269. Epub 2011 Nov 21. Erratum in: Psychol Addict Behav. 2012 Sep;26(3):506.

PMID:
22103843
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers.

Gruber SA, Silveri MM, Dahlgren MK, Yurgelun-Todd D.

Exp Clin Psychopharmacol. 2011 Jun;19(3):231-42. doi: 10.1037/a0023034.

PMID:
21480730
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla.

Silveri MM, Jensen JE, Rosso IM, Sneider JT, Yurgelun-Todd DA.

Psychiatry Res. 2011 Mar 31;191(3):201-11. doi: 10.1016/j.pscychresns.2010.10.005.

PMID:
21334181
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The dual neuroprotective-neurotoxic profile of cannabinoid drugs.

Sarne Y, Asaf F, Fishbein M, Gafni M, Keren O.

Br J Pharmacol. 2011 Aug;163(7):1391-401. doi: 10.1111/j.1476-5381.2011.01280.x. Review.

PMID:
21323910
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Altered prefrontal and insular cortical thickness in adolescent marijuana users.

Lopez-Larson MP, Bogorodzki P, Rogowska J, McGlade E, King JB, Terry J, Yurgelun-Todd D.

Behav Brain Res. 2011 Jun 20;220(1):164-72. doi: 10.1016/j.bbr.2011.02.001. Epub 2011 Feb 12.

PMID:
21310189
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cannabis and psychopathology : update 2004.

Grover S, Basu D.

Indian J Psychiatry. 2004 Oct;46(4):299-309.

PMID:
21206788
[PubMed]
Free PMC Article
11.

Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences.

Wesley MJ, Hanlon CA, Porrino LJ.

Psychiatry Res. 2011 Jan 30;191(1):51-9. doi: 10.1016/j.pscychresns.2010.10.002. Epub 2010 Dec 9.

PMID:
21145211
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, Huestis MA.

J Anal Toxicol. 2009 Oct;33(8):469-77.

PMID:
19874654
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Functional consequences of marijuana use in adolescents.

Jacobus J, Bava S, Cohen-Zion M, Mahmood O, Tapert SF.

Pharmacol Biochem Behav. 2009 Jun;92(4):559-65. doi: 10.1016/j.pbb.2009.04.001. Epub 2009 Apr 5. Review.

PMID:
19348837
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome.

Aharonovich E, Brooks AC, Nunes EV, Hasin DS.

Drug Alcohol Depend. 2008 Jun 1;95(3):279-83. doi: 10.1016/j.drugalcdep.2008.01.009. Epub 2008 Mar 7.

PMID:
18329188
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Functional MRI of inhibitory processing in abstinent adolescent marijuana users.

Tapert SF, Schweinsburg AD, Drummond SP, Paulus MP, Brown SA, Yang TT, Frank LR.

Psychopharmacology (Berl). 2007 Oct;194(2):173-83. Epub 2007 Jun 9.

PMID:
17558500
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.

Harrison I, Joyce EM, Mutsatsa SH, Hutton SB, Huddy V, Kapasi M, Barnes TR.

Psychol Med. 2008 Jan;38(1):79-88. Epub 2007 May 29.

PMID:
17532864
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Solowij N, Michie PT.

J Psychiatry Neurosci. 2007 Jan;32(1):30-52. Review.

PMID:
17245472
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Chronic cognitive impairment in users of 'ecstasy' and cannabis.

Klugman A, Gruzelier J.

World Psychiatry. 2003 Oct;2(3):184-90.

PMID:
16946933
[PubMed]
Free PMC Article
19.

Brain activity in cigarette smokers performing a working memory task: effect of smoking abstinence.

Xu J, Mendrek A, Cohen MS, Monterosso J, Rodriguez P, Simon SL, Brody A, Jarvik M, Domier CP, Olmstead R, Ernst M, London ED.

Biol Psychiatry. 2005 Jul 15;58(2):143-50. Erratum in: Biol Psychiatry. 2006 Jul 15;60(2):204.

PMID:
16038685
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk